Kidney drug tested in diabetic and non-diabetic patients
NCT ID NCT07302464
First seen Jan 11, 2026 · Last updated May 06, 2026 · Updated 13 times
Summary
This study looked at how a class of diabetes drugs called SGLT2 inhibitors affects kidney function in people with chronic kidney disease (CKD). Researchers compared 60 patients with and without diabetes to see if the drugs helped preserve kidney function. The goal was to understand if these drugs benefit all CKD patients, not just those with diabetes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Ain Shams University
Cairo, 11591, Egypt
Conditions
Explore the condition pages connected to this study.